Due to the pandemic, the pharmaceutical industry has been constantly evolving, and communication through digital media has become essential to generate a conversation not only with patients but also with health personnel. Therefore, it is essential to carry out hybrid strategies of traditional and digital media in order to keep our communication channels updated.
At ISI PHARMA it is essential to provide the necessary tools to continue being one of the main actors in health issues and thereby generate effective communication between the medical consumer, patient and the brand.
An example to share is how the agency has executed the digital campaign for the laboratory Mayoly Spindler from Mexicoa pharmaceutical laboratory of French origin specialized in gastroenterology with more than 100 years of experience.
Working hand in hand with the team marketing of mayoly, a completely digital campaign was developed in order to generate awareness and audience reach to show the benefits of the gastro portfolio in the patient.
We generate content and update messages based on a storytelling that helped us achieve the objectives set, in addition to generate digital presence talking about different diseases and issues relevant to the patient.
Thanks to our service Multichannel Marketing Pharma in the creation of content for social networks, we achieved Generate and implement a communication of interest where the patient and the doctor are able to identify the brands of the laboratory with their respective benefits in an organic way. Likewise, we developed a new graphic line for Mayoly with the aim of providing a message of interest and trust.
“In this stage of change, the inclusion of social networks and digital channels are a great opportunity for the health industry in the reach of audiences, since in In times of pandemic, patients increased their searches on the web”, Rodolfo Mendoza, Marketing Manager at Mayoly Splinder.
Finally, the mix of channels and the implementation of a strategic communication Journey provides us with a greater reach of audiences, where the mix of digital and traditional channels becomes central to Mayoly’s differentiation strategy.
Similarly, we create a upgrade between the content and the graphic line designed and executed by ISI PHARMA, all this developed by the commitment of our young talent, who contribute new ideas in the generation of innovative proposals for the pharmaceutical industry.
And it is that, in this context, it is necessary to remember that we live in an era in which the move towards digital channels has no turning back, being the youthful impetus that will carry out the total transformation in the coming years, through his inventiveness and creative abilities.
With the latter, we make it clear that the commitment to a digital transformation is real, and our success stories speak for themselves about our services and advice.
Pharma Marketing, Pharmaceutical Marketing, Pharmaceutical Industry, Marketing, IsiPharma, Isi Pharma, Disruptive Strategy, Mayoly
Social media: